Immix Biopharma Stock Price History

IMMX Stock  USD 2.97  0.05  1.71%   
If you're considering investing in Immix Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immix Biopharma stands at 2.97, as last reported on the 20th of July, with the highest price reaching 3.04 and the lowest price hitting 2.91 during the day. Immix Biopharma is very risky given 3 months investment horizon. Immix Biopharma holds Efficiency (Sharpe) Ratio of 0.19, which attests that the entity had a 0.19 % return per unit of risk over the last 3 months. We have collected data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.1% are justified by taking the suggested risk. Use Immix Biopharma Downside Deviation of 6.26, market risk adjusted performance of 0.9667, and Risk Adjusted Performance of 0.1847 to evaluate company specific risk that cannot be diversified away.
Immix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1872

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsIMMX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.88
  actual daily
52
52% of assets are less volatile

Expected Return

 1.1
  actual daily
22
78% of assets have higher returns

Risk-Adjusted Return

 0.19
  actual daily
14
86% of assets perform better
Based on monthly moving average Immix Biopharma is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immix Biopharma by adding it to a well-diversified portfolio.

Immix Biopharma Stock Price History Chart

There are several ways to analyze Immix Stock price data. The simplest method is using a basic Immix candlestick price chart, which shows Immix Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJuly 18, 20252.97
Lowest PriceApril 23, 20251.71

Immix Biopharma July 20, 2025 Stock Price Synopsis

Various analyses of Immix Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Immix Stock. It can be used to describe the percentage change in the price of Immix Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Immix Stock.
Immix Biopharma Price Rate Of Daily Change 1.02 
Immix Biopharma Price Daily Balance Of Power 0.38 
Immix Biopharma Price Action Indicator 0.02 

Immix Biopharma July 20, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Immix Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Immix Biopharma intraday prices and daily technical indicators to check the level of noise trading in Immix Stock and then apply it to test your longer-term investment strategies against Immix.

Immix Stock Price History Data

The price series of Immix Biopharma for the period between Mon, Apr 21, 2025 and Sun, Jul 20, 2025 has a statistical range of 1.31 with a coefficient of variation of 13.83. Under current investment horizon, the daily prices are spread out with arithmetic mean of 2.25. The median price for the last 90 days is 2.19.
OpenHighLowCloseVolume
07/20/2025
 2.91  3.04  2.91  2.97 
07/18/2025
 2.91  3.04  2.91  2.97  278,471 
07/17/2025
 2.95  3.12  2.91  2.92  348,639 
07/16/2025
 2.82  3.00  2.76  2.95  213,842 
07/15/2025
 2.90  3.09  2.73  2.76  217,701 
07/14/2025
 2.65  2.90  2.65  2.89  168,282 
07/11/2025
 2.70  2.74  2.61  2.65  286,916 
07/10/2025
 2.73  2.80  2.67  2.71  234,655 
07/09/2025
 2.68  2.76  2.61  2.75  172,015 
07/08/2025
 2.62  2.71  2.56  2.66  144,464 
07/07/2025
 2.60  2.65  2.45  2.62  157,616 
07/03/2025
 2.43  2.59  2.42  2.55  101,832 
07/02/2025
 2.19  2.45  2.15  2.41  218,431 
07/01/2025
 2.10  2.22  2.10  2.19  141,598 
06/30/2025
 2.19  2.20  2.05  2.07  121,451 
06/27/2025
 2.30  2.31  2.05  2.17  171,310 
06/26/2025
 2.20  2.29  2.20  2.24  166,260 
06/25/2025
 2.24  2.28  2.18  2.22  89,082 
06/24/2025
 2.16  2.30  2.16  2.24  58,160 
06/23/2025
 2.29  2.43  2.17  2.23  130,337 
06/20/2025
 2.40  2.45  2.24  2.24  139,384 
06/18/2025
 2.29  2.45  2.20  2.39  193,988 
06/17/2025
 2.41  2.46  2.26  2.28  55,703 
06/16/2025
 2.36  2.40  2.31  2.40  41,977 
06/13/2025
 2.45  2.50  2.33  2.35  48,251 
06/12/2025
 2.42  2.53  2.36  2.49  67,670 
06/11/2025
 2.42  2.65  2.34  2.43  248,702 
06/10/2025
 2.32  2.43  2.28  2.41  113,591 
06/09/2025
 2.40  2.55  2.29  2.34  329,467 
06/06/2025
 2.20  2.40  2.11  2.37  186,024 
06/05/2025
 2.08  2.22  2.07  2.19  294,588 
06/04/2025
 2.07  2.13  1.93  2.06  575,374 
06/03/2025
 2.62  3.00  1.87  2.11  1,692,778 
06/02/2025
 2.39  2.62  2.35  2.60  311,250 
05/30/2025
 2.24  2.47  2.24  2.34  304,911 
05/29/2025
 1.96  2.26  1.89  2.25  428,351 
05/28/2025
 2.00  2.01  1.94  1.95  197,938 
05/27/2025
 2.04  2.04  1.96  1.97  379,501 
05/23/2025
 2.10  2.14  1.90  1.99  1,141,421 
05/22/2025
 2.06  2.50  2.06  2.41  3,896,540 
05/21/2025
 2.08  2.15  2.07  2.09  67,851 
05/20/2025
 2.01  2.15  2.01  2.11  35,148 
05/19/2025
 2.06  2.15  2.02  2.11  100,732 
05/16/2025
 2.10  2.13  2.06  2.06  25,379 
05/15/2025
 1.99  2.10  1.99  2.09  55,982 
05/14/2025
 1.94  2.08  1.94  1.98  44,014 
05/13/2025
 2.15  2.15  1.95  1.98  48,888 
05/12/2025
 2.10  2.11  2.06  2.09  53,064 
05/09/2025
 2.10  2.22  2.04  2.09  47,479 
05/08/2025
 2.05  2.25  2.05  2.15  56,230 
05/07/2025
 2.00  2.15  1.96  2.12  25,190 
05/06/2025
 1.99  2.10  1.92  1.95  41,712 
05/05/2025
 2.12  2.14  1.98  2.03  43,007 
05/02/2025
 2.15  2.27  2.06  2.10  59,641 
05/01/2025
 2.11  2.32  2.04  2.04  276,828 
04/30/2025
 2.00  2.12  1.99  2.11  115,554 
04/29/2025
 1.95  2.04  1.90  2.02  73,999 
04/28/2025
 1.84  1.94  1.78  1.94  108,639 
04/25/2025
 1.70  1.88  1.70  1.87  68,224 
04/24/2025
 1.73  1.75  1.66  1.75  23,304 
04/23/2025
 1.74  1.79  1.64  1.71  42,461 

About Immix Biopharma Stock history

Immix Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immix Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immix Biopharma stock prices may prove useful in developing a viable investing in Immix Biopharma
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company was incorporated in 2012 and is headquartered in Los Angeles, California. Immix Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.

Immix Biopharma Stock Technical Analysis

Immix Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immix Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immix Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Immix Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Immix Biopharma's price direction in advance. Along with the technical and fundamental analysis of Immix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Immix Stock Analysis

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.